{
  "id": 19360330,
  "title": "PepGen's oligo succeeds in Phase 2; Ionis' and ImmunityBio's stocks sag",
  "url": "https://urgent.news/2026/11/10/pepgens-oligo-succeeds-in-phase-2-ionis-and-immunitybios-stocks-sag",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-10T16:09:58.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/pepgens-oligo-succeeds-in-phase-2-ionis-and-immunitybios-stocks-sag/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Coherus Oncology, JW Therapeutics and PsiThera. PepGen’s positive mid-stage results in DM1: PepGen said its oligonucleotide therapy PGN-EDODM1 showed positive early signals in a cohort of Phase 2 patients with myotonic dystrophy ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}